Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia

NCT00513305 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

67

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been stopped by sponsor decision

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Arsenic trioxide
DRUG: Low-dose cytarabine alone

Sponsor

Cephalon